Deep Track Capital, LP 13D and 13G filings for X4 Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 08:34 am Purchase | 2026-06-30 | 13G | X4 PHARMACEUTICALS INC XFOR | Deep Track Capital, LP | 8,040,894 8.330% | 5,673,899 (+239.71%) | Filing |
| 2025-08-19 4:05 pm Purchase | 2025-08-12 | 13G | X4 PHARMACEUTICALS INC XFOR | Deep Track Capital, LP | 2,366,995 9.990% | 2,366,995 (New Position) | Filing |